Prime Therapeutics Executive and Leadership Team

Manmohan Mahajan, the Chief Financial Officer at Prime Therapeutics, manages the fiscal health and economic strategy of the organization. Mahajan oversees capital allocation, financial reporting, and the budgetary frameworks that enable the delivery of transparent pharmacy benefit services. By aligning financial goals with the company commitment to affordability, the Chief Financial Officer ensures that health plans and employers receive maximum value from their pharmacy investments. Manmohan Mahajan directs the financial analysis of specialty drug programs, balancing cost-efficiency with the need for high-quality clinical support. This leadership role involves constant interaction with the Board to maintain fiscal discipline while funding growth initiatives. Through rigorous oversight of revenue cycles and operational expenses, the Chief Financial Officer sustains the financial stability necessary for the company to continue transforming the PBM model. Mahajan secures the economic resources required to support ongoing innovation in medication adherence and clinical management.

Matthew Mertel, the Chief Operating Officer at Prime Therapeutics, executes the daily operational strategies that drive pharmacy benefit efficiency. Mertel oversees the end-to-end management of pharmacy solutions, ensuring that medication access and clinical support services function seamlessly for all clients. By optimizing internal workflows and supply chain logistics, the Chief Operating Officer maintains the high standards of service required by health plans and unions. Matthew Mertel coordinates with cross-functional teams to implement programs that improve patient adherence and manage chronic health conditions effectively. This leadership role focuses on scaling operational capacity to meet the evolving needs of the healthcare market. Through the continuous refinement of service delivery models, the Chief Operating Officer ensures that the company remains a leader in transparent pharmacy management. Mertel drives operational excellence by aligning internal processes with the broader mission of delivering accessible and affordable healthcare solutions to diverse populations.

Ellyn Hosch, the Chief Information Officer at Prime Therapeutics, directs the digital infrastructure and technological roadmap essential for modern pharmacy benefit management. Hosch oversees the integration of advanced data analytics and secure platforms to ensure seamless medication access for members across the United States. By architecting scalable cloud solutions, the Chief Information Officer supports the company mission of prioritizing people over profits through enhanced digital transparency. Ellyn Hosch collaborates with clinical teams to implement robust systems that manage specialty drug data and chronic condition tracking. This leadership role drives the technological evolution of the organization, ensuring that all pharmacy solutions remain efficient and accessible. Through the deployment of cutting-edge software, the Chief Information Officer maintains the integrity of health data while fostering innovation in the pharmacy benefit space, ultimately securing the digital foundation required for long-term operational success.

Lanna Niemeyer, the Vice President - Center for Strategic Practices and Chief of Staff at Prime Therapeutics, architects the long-term strategic initiatives that define the company market position. Niemeyer oversees the Center for Strategic Practices, ensuring that all organizational efforts align with the goal of prioritizing people over profits. By facilitating communication between executive leadership and operational departments, the Vice President - Center for Strategic Practices and Chief of Staff streamlines decision-making processes. Lanna Niemeyer drives the development of innovative pharmacy solutions that address the complexities of specialty drug management and clinical support. This leadership role involves synthesizing market insights to guide the company toward sustainable growth and improved patient outcomes. Through the coordination of high-level projects, the Vice President - Center for Strategic Practices and Chief of Staff ensures that the organization remains agile and responsive to the needs of employers and health plans across the country.

Erin Feigal, the Senior Vice President and Chief Human Resources Officer at Prime Therapeutics, directs the talent strategy and organizational culture that support the company mission. Feigal oversees recruitment, employee development, and the implementation of corporate social responsibility programs that define the workplace environment. By fostering a culture of innovation and accountability, the Senior Vice President and Chief Human Resources Officer ensures that the workforce remains dedicated to improving medication access and affordability. Erin Feigal collaborates with other C-suite leaders to align human capital with the strategic goals of the organization. This leadership role involves managing the professional growth of staff who provide expert clinical support for chronic health conditions. Through the design of comprehensive benefits and engagement initiatives, the Senior Vice President and Chief Human Resources Officer maintains a high-performing team capable of transforming the PBM model. Feigal secures the talent necessary to drive long-term success in the competitive healthcare industry.

Yasmin Samra, the Vice President, Chief of Staff, Market Solutions at Prime Therapeutics, manages the strategic alignment of market-facing initiatives. Samra oversees the development of solutions tailored to the specific needs of health plans, consultants, and unions. By bridging the gap between clinical capabilities and market demands, the Vice President, Chief of Staff, Market Solutions ensures that the company delivers transparent and holistic pharmacy benefits. Yasmin Samra coordinates with sales and product teams to refine the approach to specialty drug management and medication adherence. This leadership role involves analyzing market trends to identify opportunities for growth and service expansion. Through the effective management of cross-departmental projects, the Vice President, Chief of Staff, Market Solutions supports the company mission of prioritizing people over profits. Samra drives the execution of market strategies that enhance the value proposition for clients while maintaining a focus on improving patient health outcomes across diverse regions.

Melinda Smith, the Senior Vice President and Chief of Staff at Prime Therapeutics, coordinates the executive agenda and facilitates high-level organizational alignment. Smith oversees the integration of administrative functions with the broader strategic goals of the company. By managing the flow of information between the executive team and the Board, the Senior Vice President and Chief of Staff ensures that all operations remain focused on the mission of transforming the PBM model. Melinda Smith drives the execution of key corporate initiatives that prioritize medication access and affordability for all clients. This leadership role involves overseeing complex projects that require collaboration across clinical, financial, and operational departments. Through the effective management of executive priorities, the Senior Vice President and Chief of Staff maintains the organizational focus necessary to deliver transparent pharmacy benefits. Smith supports the company commitment to corporate social responsibility by ensuring that all internal processes reflect the core values of the organization.

Amy Van Buren, the Vice President and Chief of Staff, Specialty and Clinical Solutions at Prime Therapeutics, directs the strategic development of clinical programs focused on specialty drugs and chronic condition management. Van Buren oversees the integration of clinical expertise into the pharmacy benefit model, ensuring that patients receive the support necessary for optimal medication adherence. By coordinating with clinical teams, the Vice President and Chief of Staff, Specialty and Clinical Solutions ensures that all pharmacy solutions are evidence-based and transparent. Amy Van Buren manages the operational aspects of specialty drug programs, balancing clinical efficacy with cost-effectiveness for health plans and employers. This leadership role involves driving innovation in how the company manages complex health conditions. Through the alignment of clinical strategy with organizational goals, the Vice President and Chief of Staff, Specialty and Clinical Solutions supports the company mission of prioritizing people over profits. Van Buren secures the clinical excellence required to maintain a transformative impact in the healthcare industry.